G01N 2333/775
Apolipopeptides
G01N2333/775 (Apolipopeptides) appears on 161 US grants and 370 published applications in this corpus.
Search patents in G01N- Granted patents
- 161
- Published applications
- 370
- Assignees
- 213
- Inventors
- 689
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 3 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 3 |
| 2003 | 1 | 6 |
| 2004 | 1 | 4 |
| 2005 | 0 | 7 |
| 2006 | 0 | 6 |
| 2007 | 2 | 3 |
| 2008 | 2 | 8 |
| 2009 | 2 | 14 |
| 2010 | 6 | 12 |
| 2011 | 6 | 21 |
| 2012 | 8 | 15 |
| 2013 | 7 | 17 |
| 2014 | 11 | 20 |
| 2015 | 11 | 35 |
| 2016 | 17 | 40 |
| 2017 | 8 | 25 |
| 2018 | 10 | 23 |
| 2019 | 15 | 13 |
| 2020 | 8 | 17 |
| 2021 | 8 | 18 |
| 2022 | 5 | 14 |
| 2023 | 4 | 11 |
| 2024 | 8 | 12 |
| 2025 | 10 | 16 |
| 2026 | 6 | 10 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods for apolipoprotein detection15 Sep 2026US 12,736,545 B2Biocross, S.L.
- Methods for assessing cardiovascular disease or inflammatory disease risk using non-exchangeable lipid probe2 Jun 2026US 12,644,895 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Methods and compositions for differentiating progressive chronic kidney disease from stable chronic kidney disease19 May 2026US 12,631,655 B2IDEXX Laboratories, Inc.
- Method for assisting detection of non-alcoholic steatohepatitis10 Mar 2026US 12,571,806 B2Denka Company Limited
- Egg allergy antigen24 Feb 2026US 12,558,418 B2Hoyu Co., Ltd.
- Biomarkers of amyotrophic lateral sclerosis and uses thereof17 Sep 2026US 2026/0276655 A1
- Depletion of high-abundance plasma proteins using in situ growth of metal-organic frameworks (mofs) for proteomic analysis and biomarker discovery10 Sep 2026US 2026/0266814 A1
- Compositions And Methods For Detecting Proteins In Protein Corona10 Sep 2026US 2026/0266834 A1Board of Trustees of Michigan State University
- Method for testing diseased state of vasculitis or aggravation risk of covid-19, testing kit, companion diagnostic agent, and testing marker27 Aug 2026US 2026/0251661 A1A-CLIP Institute, Co., Ltd.
- Biomarkers for huntington disease stratification, methods and uses thereof13 Aug 2026US 2026/0235626 A1
Most cited
By later US patents
- Methods, systems, and computer program products for analyzing and presenting NMR lipoprotein-based risk assessment results42US 6,576,471 B2LipoScience, Inc. · 2003
- Methods and compositions for diagnosis or prognosis of cardiovascular disease31US 8,241,861 B1Insilicos, LLC · 2012
- Nucleic acid encoding apolipoprotein E-I323US 7,771,967 B2The J. David Gladstone Institutes · 2010
- Methods for identifying compounds for the treatment of type 1 diabetes20US 8,030,288 B2BioCrine AB · 2011
- Methods of using biomarkers for predicting the outcome of an immunotherapy against cancer18US 9,389,235 B2Immatics Biotechnologies GmbH · 2016